vitreoretinopathy characterized by anomalous retinal vascular development. The principal feature of the disease is an avascular peripheral retina. This in turn can cause further pathological changes including neovascularization, exudation, hemorrhage, and retinal detachment. The biological basis of the disease is thought to be from defects in the Wnt signaling pathway. Many gene mutations have been implicated, and these can be inherited in an autosomal dominant (most common), autosomal recessive, and X-linked recessive fashion. Examination with wide-field fluorescein angiography is essential and can identify the disease in its earlier stages, enabling timely treatment, in addition to helping identify asymptomatic family members. The current treatment paradigm involves laser photocoagulation of the avascular peripheral retina for neovascular sequelae and vitreoretinal surgery for progressive retinal detachment. Further studies are underway to better characterize this complex vitreoretinopathy.
F
amilial exudative vitreoretinopathy (FEVR) is an inherited vitreoretinopathy characterized by anomalous retinal vascularization. This condition was first described in 1969 by Criswick and Schepens, 1 and it is one of several pediatric vitreoretinopathies that result from congenital abnormalities in retinal vascular development. Familial exudative vitreoretinopathy has a variable pattern of inheritance and expression; the presentation and severity of the disease can differ greatly within the same family. The genetic basis of the disease is aberrant signaling in biological pathways that impact retinal vascular development and cellular migration and differentiation. The avascular peripheral retina, which is a key feature of FEVR, manifests in the early stages and can often be entirely asymptomatic. In advanced cases, this avascular retina forms the backdrop to a host of severe complications, including the formation of fibrovascular membranes that cause vitreoretinal traction and retinal detachment (RD) that can potentially cause profound vision loss. 2 Diagnosis of FEVR entails differentiating it from other pediatric retinal diseases such as retinopathy of prematurity (ROP), Norrie disease, Coats disease, and persistent fetal vasculature.
Fluorescein angiography (FA) is crucial to the diagnosis and staging of the disease and has a great impact on treatment and follow-up. Management of FEVR is focused on preventing further progression, which can be unpredictable otherwise, in addition to treating any severe vision-threatening complications. Extraocular symptoms are uncommon, though bone-mass density problems can present in a subset of patients with FEVR, and there are other rare syndromic diseases that cause FEVR-like phenotypes.
PATHOPHYSIOLOGY
There are several genes linked to FEVR. Mutations in FZD4, which produces the receptor Frizzled-4, have been mapped to chromosomal region 11q13-q23 and identified in families with autosomal dominant FEVR. 3, 4 Mutations in NDP located on chromosome Xp11. 4 have been implicated in X-linked FEVR. NDP has classically been implicated in Norrie disease, which is characterized by progressive deafness and cognitive delay and congenital severe retinal detachment. Norrin, the protein produced by NDP, is derived from Muller cells and is involved in capillary development in the eye. 4 Genotyping around the FZD4 gene further led to the discovery of homozygous mutations implicated in families with recessive FEVR. LRP5 was identified as the first recessive FEVR gene. 5 Among FEVR-causing mutations in LRP5, nonsense mutations have been associated with autosomal recessive and sporadic forms of the disease.
2 TSPAN12 is a causative gene for FEVR that was first sought and uncovered in a set of 5 Dutch families on the basis of data from mouse studies linking the gene to retinal vascular development. It was subsequently determined to be an autosomal dominant and recessive FEVR gene. [6] [7] [8] [9] The most recent gene to be implicated in the pathogenesis of FEVR is ZNF408, discovered as a disease-causing mutation in 3 families with autosomal dominant FEVR.
10 KIF11 mutations have also been recently identified to cause a syndrome with a FEVR-like phenotype characterized, in addition, by microcephaly.
11
Wnt Signaling Pathway and FEVR Mutations in the above genes have been implicated in abnormal signaling of known biological pathways, including the Wnt signaling pathway. Wnt signaling regulates cell survival, differentiation, proliferation, and migration. In the retina, the Wnt signaling cascade orchestrates normal retinal vascular formation.
There are 2 pathways by which Wnt exerts transcriptional control over genes responsible for eye organogenesis and angiogenesis. The canonical pathway involves activation of β-catenin, whereas the noncanonical pathway involves calcium signaling. In addition to the 2 Wnt signaling pathways, the Norrin signaling pathway has also been implicated in angiogenic retinal abnormalities. The genes that participate in the Wnt canonical pathway also participate in the Norrin signaling pathway, with both These target genes include c-Myc, Cyclin D1, and VEGF. 12 The Wnt noncanonical pathway mediates cytoskeletal organization and cell migration. The Wnt noncanonical pathway shares some of the same aberrant genes that disrupt the Wnt canonical and Norrin pathways. Given that new blood vessel formation requires endothelial cell differentiation and migration along with morphogenic movement during vessel expansion, one may hypothesize a role for these Wnt pathways in retinal angiogenesis through upregulation of endothelial cell growth via the canonical pathway, followed by stimulation of cytoskeletal rearrangement and subsequent expansion of cells to form new vessels through the noncanonical pathway.
12
FZD4 and LRP5 encode the proteins that act as coreceptors for Wnt proteins and Norrin. 2, 6 TSPAN12 plays a role in Norrin signaling only; it is hypothesized that Norrin and TSPAN12 work cooperatively to induce the multimerization of the FZD4-LRP5 complex to induce β-catenin signaling. 2, 6 These mutations account for ~50% of genetically confirmed FEVR. 11 In the absence or dysfunction of the receptors and proteins encoded by these genes, β-catenin signaling cannot be activated. This results in cytoplasmic β-catenin becoming phosphorylated and targeted for degradation through the ubiquitin-proteasome pathway, and thus prospective target genes remain repressed. When Frizzled-4, LRP5, and TSPAN12 do bind to Wnt or Norrin, they transduce a signal that inhibits the destruction of β-catenin, allowing it to accumulate within the cytoplasm and subsequently translocate to the nucleus. 2 The noncanonical pathway also involves activation of intracellular signaling subsequent to FZD4 binding. Unlike the canonical pathway, LRP5 is not needed for signal transduction in the noncanonical pathway.
ZNF408 has been identified as a putative causative gene in FEVR families.
10 KIF11 mutations have also been identified in patients with FEVR; these mutations are associated with a rare autosomal dominant inherited syndrome called microcephaly with or without chorioretinopathy, lymphedema, or mental retardation (MCLMR). 13 In the largest cohort study of FEVR screening for KIF11 mutations, a mutation detection rate of 4.93% was noted (as compared with ~7-8% in prior studies). All identified probands with KIF11 in this study were found to be in advanced stages of the disease (stage 4 or above). Shared clinical features of advanced FEVR and MCLMR included retinal folds, retinal detachment, cataracts, and microphthalmia, and some patients with FEVR can have features of MCLMR with microcephaly, chorioretinopathy, mental retardation, and microphthalmia. 11 
Animal Studies
Mouse studies provide some indication of the functional role of these genes in angiogenesis and retinal development. Loss of FZD4 leads to defective vascular growth and chronic absence of intraretinal capillaries in knockdown mice. 14 The absence of FZD4 retards endothelial cell migration along the retinal surface, eliminates vascular arborization within the retina, and greatly delays programmed regression of the hyaloid vasculature. 15 Similarly, hyperpermeable retinal vessels have been observed in homozygous mutant LRP5 knockout mice, suggesting a role in maturation and lumen formation of capillaries that connect inner and outer plexiform layers. 16 In a study of mice simulating
Norrie disease, the development of the superficial retinal vasculature was strongly delayed, whereas the deep retinal vasculature did not form because of the blockage of vessel outgrowth into the deep retinal layers. 17 Knockdown of the ZNF408 gene in zebrafish has been shown to produce defects in developing retina and trunk vasculature. In vivo studies in zebrafish and chicken embryos reveal that KIF11 encodes a mitotic kinesin that is involved in the development of malignant cancer and angiogenesis. Defective KIF11 protein inhibits endothelial cell proliferation and migration in vitro. Familial exudative vitreoretinopathy due to KIF11 mutations represents a mechanism that leads to incomplete development of the retinal vasculature that is distinct from the Wnt signaling pathway.
Genetic and Phenotypic Correlations in FEVR
Familial exudative vitreoretinopathy is a genetically and phenotypically heterogeneous disease, with high levels of penetrance (75-100%) but marked variation in expressivity. 2, 19, 20 Many of the hitherto discovered genes implicated in FEVR are those involved in the Wnt signaling pathways. The most common mode of inheritance is autosomal dominant. The autosomal dominant mode is associated with mutations in FZD4 and LRP5. Mutations in LRP5 are also associated with autosomal recessive FEVR, whereas Xlinked recessive forms of the disease can be caused by mutations in NDP. 21, 22 Heterozygous mutations in TSPAN12 can cause autosomal dominant FEVR. 8 Approximately 40% to 50% of patients diagnosed with FEVR are found to have a corroborating genetic mutation identified; however, the contribution of any given gene to the disease differs among study populations. [23] [24] [25] The presentation of FEVR is reliably indistinguishable by genotypic source at the current time; however, one phenotype is very specific: bone mass abnormalities. LRP5 mutation carriers remain the only subset of FEVR that can be clinically distinguished by the presence of low bone-mass density, and the syndrome is called osteoporosis-pseudoglioma syndrome. 8 The "pseudoglioma" is in reference to lesions that seem to be "retinal gliomas," which are in fact the tractional retinal detachments seen in FEVR.
The retinal phenotype in Norrie disease, which is also caused by NDP mutations, is more severe and dysgenic than classic FEVR and is usually detected within 3 months of life, whereas FEVR is detected at various stages. Different mutations in the NDP gene also seem to associate predictably with Norrie disease versus FEVR. Wu et al 26 analyzed NDP mutations in 5 patients with Norrie disease and 4 with FEVR, finding that patients with Norrie disease had mutations involving a cysteine residue in the Norrin protein, whereas mutations in noncysteine residues of the Norrin protein showed abnormal vascular and retinal development more consistent with X-linked FEVR. Mutations disrupting the cysteine-knot motif corresponded to severe retinal dysgenesis, whereas patients with noncysteine mutations had varying degrees of avascular peripheral retina, extraretinal vasculature, and subretinal exudate. 26 Although NDP mutations are involved in both Norrie disease and FEVR, overall most mutations are linked to Norrie disease, whereas a smaller percentage cause X-linked FEVR. 2 We are, however, realizing more recently that there is a broad spectrum of Wnt signaling abnormalities and that definitive diagnoses of FEVR versus Norrie disease cannot always be made.
Identification of NDP, FZD4, LRP5, TSPAN12, and ZNF408 disease-causing alleles and next-generation sequencing of large cohorts of patients with FEVR have demonstrated a ~50% rate of genetic confirmation of the disease. 2, 7, 25, 27 In a study of Korean patients diagnosed with FEVR who screened negatively for NDP mutations, Seo et al 24 found that ~35% of patients were found to be genetically confirmed for FEVR using a mutation screening panel that included FZD4, LRP5, TSPAN12, ZNF408, LGR4, and ATOH7. Among these patients, FZD4 accounted for the largest share of FEVR cases (~72%), followed by LRP5 (~22%) and TSPAN12 (~6%). Patients with FZD4 were found to have the mildest phenotype of FEVR based on stage and visual acuity in their series. 24 Poulter et al 8 found that mutations in TSPAN12 accounted for 10% of FEVR cases in a patient series, a figure likely inflated by the fact that a majority of the patients in the study had already been excluded as carrying mutations in FZD4, LRP5, and NDP. 8 
Natural History of the Disease
When it was first reported in 1969, FEVR was described as a progressive disease with severe pediatric ocular complications. 1 In 1980, Ober et al 19 presented a case series that challenged this prevailing wisdom and stated that the disease may be asymptomatic and nonprogressive. Reporting cases from 3 families affected by autosomal dominant FEVR, the authors concluded that fundus changes and visual threat were rare after childhood and adolescence, given that in their case series the disease was not more advanced in older patients as compared with younger patients within families and no patients reported loss of vision after 20 years of age. Although symptoms do typically take a progressive course during childhood and adolescence and can become latent after 20 years of age, 23 more recent observations in the literature emphasize the threat of late progression of the disease with complications such as neovascularization, vitreous hemorrhage, and retinal detachments that can occur at any age after varying periods of apparent quiescence. 20, 28 Patients with FEVR may have reactivation of the disease process and loss of vision as late as in their 40s. 23 A key pathological aspect of this disease is the presence of peripheral retinal avascularity, most readily observed in the temporal periphery, which often has a V-shaped pattern. Moderate to severe cases can demonstrate retinal neovascularization and fibrosis at the junction between vascular and avascular retina, which can lead to traction of the macula and retinal vessels resulting in varying degrees of macular ectopia, tractional retinal detachment, and visual dysfunction. In severe cases, the traction can lead to total retinal detachment. 1, 4, 19, 20, 23, 29 Thus, progressive traction causing retinal detachment and vitreous hemorrhage may be construed as the major threat to vision in patients with FEVR. Emphasis is often placed on the treatment of peripheral retinal vascular changes; however, retinal vessel abnormalities are typically more widespread, with fluorescein leakage evident over a wide area of the retina. 19 
DIAGNOSIS Hallmark Clinical Findings
In 1969, Criswick and Schepens 1 reported 6 cases of a hitherto unclassified pediatric vitreoretinopathy that they then termed FEVR. They described a pathological condition characterized by dragging of retinal blood vessels and displacement of the macula secondary to traction, with an increased number and caliber of new vessels in the periphery (especially in a temporal fashion) that were subject to recurrent hemorrhage. Other notable findings on examination included peripheral exudation, vitreous opacities, and macular edema; occasional retinal breaks and degenerative changes; and localized retinal detachment often forming a broad fold extending temporally from the disc. This condition bore many similarities to the known pathological features of retrolental fibroplasia (ie, ROP), except that these patients were born with normal birth weight, in the absence of prematurity or supplemental oxygen administration, and with bilateral, slowly progressive ocular changes that seemed to have a hereditary component. 1 The authors hypothesized that the vitreous contraction and extensive vitreoretinal adhesions evident in these cases caused traction, resulting in kinking of retinal vessels and the creation of a hypoxic environment that spurred neovascularization. Halting of the disease process was attempted with photocoagulation of abnormal, proliferating, and leaking vessels. Treatment of sequelae, namely, retinal detachments, was accomplished through scleral buckling surgeries. 1 Since then, multiple case series in different populations have corroborated their diagnostic findings. Although the classic presentation of a pediatric patient born full term with a positive family history of ocular disease and found to have radial retinal fold provides a relatively straightforward diagnosis of FEVR, it is possible to correctly diagnose more ambiguous cases of FEVR by paying attention to certain clinical characteristics and demographic features in patients suspicious for FEVR. The presence of bilateral avascular peripheral retina is a sine qua non of this disease. Birth at full term or mildly premature birth without supplemental oxygenation is usually helpful for differentiating from ROP, along with the progressive rather than regressive nature of the pathological retinal changes. Familial presentation is another notable feature of FEVR that can provide further evidence for the diagnosis; however, a negative family history is of little help given that a positive family history of FEVR can be present in less than 10% of some cohort studies and in up to ~50% of other studies. 1, 19, 20, 23, 29, 30 On the other hand, actual peripheral retinal examinations with wide-field FA of family members can be very helpful.
Clinical examination alone can be insufficient to identify the subtle vascular changes of early-stage FEVR, requiring the aid of wide-field FA. 23 The significance of this is robustly demonstrated in a case series by Kashani et al 23 of 74 subjects from 17 families at a tertiary care practice. The authors found that, though the vast majority (71%) of index patients had late-stage FEVR and poor visual acuity, over half of their asymptomatic relatives demonstrated clinical and angiographic findings consistent with early stages of the diseases and a third were found to have avascular retina with exudate or were at risk of developing exudate. 23 With respect to demographics, the average age of index patients in the case series by Kashani et al 23 was 7 years (ranging from less than 1 month to 47 years), whereas the average age of the relatives was 16 years (1 month to 57 years). Shukla et al 20 report a case series with a predominantly older population consisting of 38 Indian patients and 23 family members with an average age of 23.6 years, presenting predominantly with diminution of vision. 20 With respect to disease severity at presentation, in the Shukla et al 20 case series, prevalence of severe disease was 50% in the group aged 10 years or younger and 24% in the group aged 20 years or older. The higher age of patients in this cohort could potentially explain the relatively high presenting visual acuity in at least 1 eye (6/12 or better) in 75% of the patients in this cohort, but on closer look visual acuity was skewed towards 6/12 or better within the group aged 10 years or younger and in the group aged 20 years or older. No difference in symmetry or asymmetry of disease stage between eyes was noted between age groups. 20 In the Ranchod et al 29 case series, 50 of 117 patients (43%) presented with the same clinical stage in both eyes, whereas 83 of 117 (71%) had bilateral disease processes within 1 stage of each other. Furthermore, of the 91 patients that presented with retinal detachment, there was a high propensity towards retinal detachment in the fellow eye as well (62 out of 91; 68%). 29 Nearly all studies show relatively equal numbers of male and female patients with the exception of 2 studies on surgical management of FEVR-associated rhegmatogenous retinal detachment (RRD), which found male predominance in cases of FEVRassociated RRD (but not in exudative or tractional RD). 31, 32 Rhegmatogenous complications seem to be more common in Asian cohorts, but it is currently not understood why.
Ranchod et al 29 described common presenting features in patients diagnosed with FEVR in their retrospective review of 273 eyes of 145 patients referred to a tertiary care practice. In their cohort, which had an average age of 6 years (range, less than 1 month to 42 years), a positive family history for FEVR was obtained in 26 patients (18%), but notably an additional 28 patients (19%) had a family history of ocular disease potentially consistent with undiagnosed FEVR. The most common referring diagnosis for patients to this tertiary level practice was FEVR (28%), followed by retinal detachment (11%). Slightly less common were referrals for ROP, retinal folds, and a family history of FEVR.
Severity of disease stage at the time of diagnosis (see Table  1 29 Retinal detachment occurs in 21-64% of affected individuals. 4 In the series by Ranchod et al, 29 64% of eyes series presented with some degree of RD and 63% of patients presented with some degree of RD in both eyes. Shukla et al 20 reported that 48% of eyes in their case series of relatively older patients demonstrated some form of RD. They noted that nonrhegmatogenous retinal detachments were present in 16 (12.9%) eyes and RRD in 20 (17.2%) eyes. Retinal breaks without RRD were present in 20 (17.2%) eyes and macular ectopia in 12 (10.3%) eyes. Based on highest stage of disease in either eye. 33 With respect to the presentation of retinal folds in FEVR, Criswick and Schepens 1 noted a propensity for folds that were exclusively temporal in location. In the series by Ranchod et al, 29 the most common retinal folds were radial (28%), typically extending from the optic nerve temporally or inferotemporally.
Fluorescein Angiographic Findings
Over half of asymptomatic family members of patients with FEVR can have subclinical findings that are only visible on widefield FA, and use of wide-field FA also illustrates the immense variation in the disease process and its anatomic presentation. 23, 33 Subtle findings include peripheral vascular abnormalities, such as a peripheral avascular zone, vitreoretinal adhesions, venousvenous anastomoses, and supernumerous vascular branching. Kashani et al 33 describe a plethora of other vascular anomalies present in FEVR using wide-field FA.
Familial exudative vitreoretinopathy is characterized by peripheral nonperfusion, with vascular abnormalities in the distal retinal vasculature. Telangiectasias can be present in the macula or periphery but are most commonly observed at the terminal ends of vessels abutting the vascular-avascular junction. Dye leakage from these lesions indicates active progressive disease. Areas of capillary agenesis and supernumary branching are also seen adjacent to vascular-avascular junctions. Extraretinal neovascularization is also observed at this junction. Aberrant circumferential vessels may also be apparent in the far periphery and are associated with venous-venous shunting. Delayed arteriovenous transit is common in cases with pronounced vascular dragging or prominent venous-venous shunting, possibly due to increased vascular resistance from decreased capillary density or due to an absolute increase in the length of vascular channels from dragging of tissues. 33 Fluorescein angiography is critical to diagnosis and management in FEVR. Fluorescein leakage without clinical exudation is thought to be the precursor to the exudative phase of the disease. Because exudation can complicate treatment with laser photocoagulation, detection of leakage with FA is critical to timely treatment before exudative changes. 33 
Microstructural Features
Optical coherence tomography (OCT) allows for identification of posterior segment microstructures present in FEVR, including posterior hyaloidal organization, vitreomacular traction, vitreopapillary traction, diminished foveal contour, persistent fetal foveal architecture, cystoid macular edema, intraretinal exudates, and distortions of the ellipsoid zone. Disorganized posterior hyaloid is most common in higher stages of FEVR; persistent foveal architecture is most common in stage 2, and macular edema presents most frequently in stages 2 and above, often accompanied by intraretinal exudation. Disruption of the ellipsoid zone is associated with stages 3 to 5 of FEVR and is associated with poorer vision.
The dysgenic vitreous in FEVR can be pathologically adherent and contractile. Apart from its pathological importance, the hyaloidal contraction is also significant for surgical management. Hyaloidal sheets can be difficult to visualize intraoperatively and are broader than typical epiretinal membranes that arise after posterior vitreous detachments; multilayered posterior hyaloid results in higher incidence of recurrent premacular proliferative tissues. Understanding the various contractile vectors is important for planning surgical release of the traction. 34 Yonekawa et al 34 have demonstrated the functional correlations between visual acuity and microstructural abnormalities. In early stages of the disease, disorganized posterior hyaloid, macular edema, exudates, and disrupted ellipsoid zone were associated with poor visual acuity. The presence of any of these OCT microstructural phenotypes can be helpful in triaging patients in whom a peripheral retinal examination and wide-field FA can be considered.
Histopathologic Findings
Histopathologic analysis of eyes enucleated for complications from FEVR demonstrate retinal detachment, peripheral retinal vascular proliferation, and fibrovascular preretinal membranes. Inflammation and necrosis can be present in and around the fibrovascular tissue. 4 Abnormal intraretinal vessels can result in subretinal hemorrhages, and these eyes also demonstrate intraretinal and subretinal exudates. The anterior surface of the retina can be degenerated, disorganized, covered with membranes, and associated with nodular densities of fibrovascular tissue. The retinal vessel walls show thickening, telangiectasias can be present, and peripheral retinal vessels can be occluded. 35 
Differential Diagnosis
Although a positive family history can support a diagnosis of FEVR, a negative family history is of little help. This is because many family members with FEVR are asymptomatic and are not aware of the diagnosis, and many cases do represent de novo mutations. 29 As noted previously, FEVR can be distinguished from ROP by its familial pattern, progression in the years after birth, and absence of prematurity or supplementary oxygenation at birth. With ROP, the underlying acute disease itself usually does not progress or recur in childhood or adulthood [unless treated with anti-vascular endothelial growth factor (anti-VEGF) agents]. 29 The FA findings in FEVR also differ subtly from FA findings in ROP, as in the latter there is often a vascular ridge representing arteriovenous shunting. In contrast to Coats disease, FEVR is a bilateral disease process with significantly greater vitreous pathology. 1 Coats is unilateral in 90% of cases and usually affects young males. 4 Very young male patients with a severe ocular phenotype and hearing loss with or without intellectual disability have a higher likelihood of Norrie disease as compared with FEVR. 2 However, the hearing loss and cognitive delay in Norrie disease often do not manifest until the children are slightly older. Retinal folds can be confused for a persistent fetal vasculature stalk as well. 22 Persistent fetal vasculature is typically sporadic
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and unilateral. 4 Many patients with so-called "congenital falciform folds" likely have FEVR. 29 
MANAGEMENT

Screening and Examination Recommendations
Screening of asymptomatic family members may facilitate the diagnosis and genetic counseling for those of child-bearing age so that future infants can be screened appropriately for FEVR. Considering that FEVR is a lifelong disease, and that progression can be dramatic and unpredictable, regular follow-up is advised.
Nonsurgical Treatment Strategies
Presence of angiographic leakage, particularly in the area of the vascular-avascular junction, can be treated with laser photocoagulation of the avascular peripheral retina. 33 Kashani et al 33 advocate early laser treatment in eyes with angiographic leakage or exudation, given that FEVR can progress in a linear fashion or skip stages. However, the vitreoretinopathy can still progress with worsening vitreoretinal traction that results in vitreous hemorrhage or detachment. The mechanism of progressive tractional detachment may be related to the rapid reabsorption of subretinal exudates or to the upregulation of transforming growth factor B, which occurs in response to decreased levels of VEGF. 36 Anti-VEGF therapy may help to reduce exudation and neovascularization in FEVR but studies note that the rapid resolution of exudation can potentially stimulate worsening vitreoretinal traction. 37 Laser remains the mainstay of treatment for FEVR, as it has lasting effects, and the vitreous contraction is thought to be less dramatic than after anti-VEGF treatment. Anti-VEGF therapy may have a role as an adjunctive modality before surgery to decrease the VEGF load in very active eyes that may be prone to bleeding. 4 The use of anti-VEGF for FEVR still requires further investigation.
Management of Retinal Detachment
The purpose of surgical intervention is to relieve tractional forces through scleral buckling and/or removal of the vitreous. Indication for surgery is determined by type of retinal pathology and the status of the fellow eye. For example, in an eye with a chronic and severe total retinal detachment where the fellow eye has normal vision, observation may be warranted, whereas in a young patient with progressive bilateral total RD diagnosed early, vitrectomy may be recommended in 1 or both eyes. 37 Surgical outcomes generally vary by severity of disease and surgical approaches pay deference to the unique tractional forces threatening anatomical resolution along with associated ocular complications. 20, [30] [31] [32] 37 Scleral buckling and vitrectomy provide 2 approaches for managing retinal detachment. Buckling for tractional retinal detachment may not be the first approach that surgeons think of in today's era of small gauge vitrectomy, but it is an attractive, less invasive way to support the area of traction to relieve both the traction and the underlying vascular activity. If there are clear tractional vectors that need to be cut, or lensectomy that needs to be performed due to fibrovascular adhesion to the posterior capsule, vitrectomy would be indicated. Total retinal detachment would also require vitrectomy intervention. Care must be taken not to create any iatrogenic breaks during cannula placement. In stages 3 or 4, the peripheral retina should be well inspected 30 Shukla et al 20 Chen et al 31 Yamane et al to confirm the availability of the pars plana or plars plicata for trocar insertion. When in doubt, or in stage 5 eyes, the incisions should be created anteriorly at the limbus or iris root. An iatrogenic retinal break in pediatric tractional retinal detachment can quickly lead to an inoperable state. Outcomes for surgical repair of FEVR-associated RD in multiple case series are summarized in Table 2 . 20, [30] [31] [32] [37] [38] [39] [40] [41] One important consideration is when not to operate. We discussed above when observation can be considered for stage 5 retinal detachment with poor prognosis. For stage 3, the macula is attached and vision is presumably good. The retinal detachment can be expected to stop progressing if the avascular retinal periphery is treated with laser photocoagulation, in which case the retinal detachment can be treated with observation, especially if it is focal and far in the periphery. For stage 4, these eyes normally involve a retinal fold. The folds can be vascularly active and broad with edema and exudation. These types of folds are amenable to surgical intervention. By contrast, thin folds with retina-retina adhesion without any vascular activity should be observed, 34 as the risk is high for making iatrogenic breaks, and vision often does not improve even if these folds are released. These folds also may require lensectomy, which deprives the eye of visual development and subjects it to aphakic glaucoma.
CONCLUSIONS
The first descriptions of FEVR almost 50 years ago beautifully illustrated that the condition is an inherited vitreoretinopathy. Since then, we have learned much about the underlying pathophysiology, genetics, diagnosis, and management. We have learned that the Wnt signaling pathway is implicated and likely at the core of this retinal developmental abnormality. Interestingly, we are uncovering many other syndromes that have FEVR phenotypes but may be distinct entities. From the diagnostic standpoint, wide-field fluorescein angiography has become the gold standard in the diagnosis and monitoring of these patients. The angiography can be performed in clinic, or for younger children, during examinations under anesthesia. Early laser photocoagulation helps to prevent progression of disease, and carefully selected vitreoretinal interventions can help our patients improve or maintain vision, though future studies will hopefully further improve outcomes.
